Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation

Archive ouverte

Cosson, Camille | Riou, Romane | Patoli, Danish | Niu, Tingting | Rey, Amaury | Groslambert, Marine | de Rosny, Charlotte | Chatre, Elodie | Allatif, Omran | Henry, Thomas | Venet, Fabienne | Milhavet, Florian | Boursier, Guilaine | Belot, Alexandre | Jamilloux, Yvan | Merlin, Etienne | Duquesne, Agnès | Grateau, Gilles | Savey, Léa | Jacques Maria, Alexandre, Thibault | Pagnier, Anne | Poutrel, Solène | Lambotte, Olivier | Mallebranche, Coralie | Ardois, Samuel | Richer, Olivier | Lemelle, Irène | Rieux-Laucat, Frédéric | Bader-Meunier, Brigitte | Amoura, Zahir | Melki, Isabelle | Cuisset, Laurence | Touitou, Isabelle | Geyer, Matthias | Georgin-Lavialle, Sophie | Py, Bénédicte, F

Edité par CCSD ; Rockefeller University Press -

International audience. NLRP3-associated autoinflammatory disease is a heterogenous group of monogenic conditions caused by NLRP3 gain-of-function mutations. The poor functional characterization of most NLRP3 variants hinders diagnosis despite efficient anti-IL-1 treatments. Additionally, while NLRP3 is controlled by priming and activation signals, gain-of-functions have only been investigated in response to priming. Here, we characterize 34 NLRP3 variants in vitro, evaluating their activity upon induction, priming, and/or activation signals, and their sensitivity to four inhibitors. We highlight the functional diversity of the gain-of-function mutants and describe four groups based on the signals governing their activation, correlating partly with the symptom severity. We identify a new group of NLRP3 mutants responding to the activation signal without priming, associated with frequent misdiagnoses. Our results identify key NLRP3 residues controlling inflammasome activity and sensitivity to inhibitors, and antagonistic mechanisms with broader efficacy for therapeutic strategies. They provide new insights into NLRP3 activation, an explanatory mechanism for NLRP3-AID heterogeneity, and original tools for NLRP3-AID diagnosis and drug development.

Suggestions

Du même auteur

NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly

Archive ouverte | Niu, Tingting | CCSD

International audience. Abstract NLRP3 controls the secretion of inflammatory cytokines IL-1β/18 and pyroptosis by assembling the inflammasome. Upon coordinated priming and activation stimuli, NLRP3 recruits NEK7 wi...

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Archive ouverte | Avouac, Jérôme | CCSD

International audience. Background: Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab c...

Performance of serum IL-18 levels for the follow-up of patients with familial Mediterranean fever

Archive ouverte | Elhani, Inès | CCSD

International audience. Serum total IL-18 levels are elevated in familial Mediterranean fever (FMF) in a gene-dose–dependent manner. It has poor performance in distinguishing disease activity but may indicate low or...

Chargement des enrichissements...